Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer (CRUCIAL)

  • End date
    Mar 19, 2026
  • participants needed
  • sponsor
    Jinling Hospital, China
Updated on 7 October 2022


Gastric cancer patients with stage III will be randomized to immune nutrition support or control group at discharge after total gastrectomy. Patients will receive 6 months of immune nutrition support or normal diet after discharge. The primary and secondary outcomes will be collected.


Gastric cancer patients with stage III after total gastrectomy at discharge, if she/he has nutrition risk (NRS2002≥3), then she/he will be randomized to immune nutrition support (INS) or control (C) group after discharge. In the INS group, in addition to diet, and patients will also consume two bottles per day of a high-calorie, high-protein ONS and three capsules of fish oil lasted for 6 months. In the C group, patients will receive normal diet. Both groups will receive nutrition counseling.

The primary and secondary outcomes will be collected.

Condition Stage III Gastric Cancer
Treatment ONS
Clinical Study IdentifierNCT05253716
SponsorJinling Hospital, China
Last Modified on7 October 2022


Yes No Not Sure

Inclusion Criteria

Informed consent of patients or their legal representatives to participate in this study
consecutive adult (≥18 years) patients underwent radical gastrectomy (total gastrectomy) with pathological TNM stage III
nutrition Risk Screening (NRS) 2002≥3 at discharge
eastern Cooperative Oncology Group (ECOG) score of 0-2 at discharge

Exclusion Criteria

unable to oral or consume ONS
has received neoadjuvant chemotherapy
palliative surgery or gastric stump cancer or Borrmann type IV
oral anticoagulants cannot be stopped; congenital acquired immune deficiency disease
serious cardiovascular disease including chronic heart failure, angina pectoris, myocardial infarction, arrhythmias (such as atrial fibrillation), or uncontrolled hypertension
severe liver and kidney diseases including active hepatitis, cirrhosis, and uremia
diabetes has developed complications or uncontrolled by medications
previous use of drugs affecting immune function
previous use of fish oil capsule > 2 times / week or contraindications to fish oil capsule
motor system diseases cannot complete grip strength measurement and 5-time chair stand test
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note